Press releases
2017
1 December, 2017
First patient included in Phase I study aiming at supporting expansion of global Phase III program for PledOx® to include Asian patients
20 November, 2017
PledPharma and Solasia enter license agreement to develop and commercialize PledOx® in Asia
16 November, 2017
PledPharma initiates Phase III studies with PledOx® before year end 2017
7 November, 2017
PledPharma appoints Yilmaz Mahshid as new CFO
20 October, 2017
Interim report January - September 2017
15 September, 2017
PledPharma’s CFO to leave the company in December 2017
14 September, 2017
The Aladote study in patients treated for paracetamol overdose is now open for recruitment for the next dosage group
30 August, 2017
Interim report January - June 2017
24 August, 2017
PledPharma establishes a Scientific Advisory Board for the continued clinical development of PledOx®
17 August, 2017
PledPharma appoints a Chief Medical Officer
29 June, 2017
PledPharma strengthens the management team with a Vice President Product Strategy and Development
25 April, 2017
Interim report January – March 2017
6 April, 2017
PledPharma Appoints Nicklas Westerholm as New CEO
24 February, 2017
Year end report January – December 2016